Therefore, changes in the expression of these genes following siRNA-mediated ILK depletion in cisplatin-resistant ovarian cancer cells could explain in part the reduction in cell growth, invasion, and viability, and the increase in caspase-3 activity. The gene discussed is CASP3; the disease is ovarian carcinoma.